---
title: "Former WuXi Biologics Chief Technology Officer Zhou Weichang joins Yilian Biologics"
description: "Yilian Biologics announced on July 1st the appointment of Dr. Zhou Weichang as Chief Technology Officer. His extensive experience in the biopharmaceutical field will assist the company in the global d"
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/246760280.md"
published_at: "2025-07-01T02:28:40.000Z"
---

# Former WuXi Biologics Chief Technology Officer Zhou Weichang joins Yilian Biologics

> Yilian Biologics announced on July 1st the appointment of Dr. Zhou Weichang as Chief Technology Officer. His extensive experience in the biopharmaceutical field will assist the company in the global development of innovative pipelines. Zhou Weichang has held several important positions at WuXi Biologics and served in senior leadership roles at Genzyme, PDL BioPharma, and Merck

On July 1st, Yilian Biologics announced the official appointment of Dr. Zhou Weichang as the company's Chief Technology Officer. The company stated that Dr. Zhou's extensive industry experience in biomedicine will help Yilian Biologics strengthen the global development process of its innovation pipeline. Previously, Dr. Zhou held important positions such as Executive Director, Chief Technology Officer, and Global Biologics Development and Operations President at WuXi Biologics. Before joining WuXi Biologics in 2012, he held senior leadership positions in the CMC teams at well-known institutions such as Genzyme Corporation, PDL BioPharma Inc., and Merck & Co. Inc

### Related Stocks

- [WXXWY.US - WuXi Biologics](https://longbridge.com/en/quote/WXXWY.US.md)
- [02269.HK - WUXI BIO](https://longbridge.com/en/quote/02269.HK.md)
- [399441.CN - CNI BIOMEDICINE](https://longbridge.com/en/quote/399441.CN.md)
- [MRK.US - Merck](https://longbridge.com/en/quote/MRK.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| 15:02 ETDisrupting Chronic Cough: Julian Circo Brings AI to the World's Oldest Symptom | Julian Circo, Co-Founder of Hyfe, discusses on the Disruption Interruption podcast how his company is revolutionizing re | [Link](https://longbridge.com/en/news/276373106.md) |
| Labcorp Holdings Stock: Is Wall Street Bullish or Bearish? | Labcorp Holdings Stock: Is Wall Street Bullish or Bearish? | [Link](https://longbridge.com/en/news/276331774.md) |
| U2 releases song 'American Obituary' honoring Renee Good | U2 has released a song titled "American Obituary" as a tribute to Renee Good, a mother killed by an ICE officer in Minne | [Link](https://longbridge.com/en/news/276275369.md) |
| Starbucks India Expands Store Network, Localizes Menu Despite Rising Losses | Starbucks India Expands Store Network, Localizes Menu Despite Rising Losses | [Link](https://longbridge.com/en/news/276449752.md) |
| Demystifying Garmin: Insights From 4 Analyst Reviews | Garmin (NYSE:GRMN) received mixed ratings from 4 analysts over the past three months, with an average 12-month price tar | [Link](https://longbridge.com/en/news/276365030.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.